Key result
Recurrent early HeartMate II LVAD pump thrombosis leads to fatal outcome despite device exchange.
Why the study?
Pump thrombosis remains a significant complication of left ventricular assist devices, with challenges in diagnosis and management, especially early after implantation.
Case Report (n=1)
No
Recurrent early HeartMate II thrombosis proved fatal despite exchange; this case leaves open optimal prevention strategies in young LVAD recipients.
Left ventricular assist devices are becoming an established treatment for end-stage heart failure. In spite of their proven benefit, pump thrombosis remains a significant complication. Here we describe the challenging management of a patient with recurrent pump thrombosis.
No takes yet. Share an insight, caveat, or question.
Capoccia et al. (2013) conducted a case report in Dilated cardiomyopathy and severe left ventricular systolic dysfunction (n=1). HeartMate II Left Ventricular Assist Device was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: